TruTag Technologies
Emeryville, US · Delaware corporation · 1 known investors
Trutags operates in clinical trial management and healthcare technology, though this page profiles a board member rather than describing the company's core business. The page does not contain sufficient information about Trutags' own products or services.
Founders & leadership
LL
Leslie LeffDirector
JP
James PappasDirector
MB
Michael BartholomeuszExecutive Officer, Director
MM
Mark MaciejewskiDirector
AP
Albert PleusDirector
GL
Gregory LeongDirector
PM
Peter M. O. WongExecutive Officer
MO
Michael O'Neill, Ph.D.Executive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$14.7MraisedNov 2021 · 12 investors · PharmaceuticalsRule 506(b)
▶$14.7MraisedNov 2021 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael O'Neill, Ph.D.Executive Officer
- Sean KaramchandaniDirector
- Jennifer McFarlaneDirector
- Leslie LeffDirector
- Matthew CohenDirector
- Peter M. O. WongExecutive Officer
- Gregory LeongDirector
- Michael BartholomeuszExecutive Officer, Director
- Albert PleusDirector
- Offering amount
- $24.2M
- Amount sold
- $14.7M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25.5MraisedSep 2019 · 30 investors · PharmaceuticalsRule 506(b)
▶$25.5MraisedSep 2019 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Leslie LeffDirector
- James PappasDirector
- Michael BartholomeuszExecutive Officer, Director
- Mark MaciejewskiDirector
- Albert PleusDirector
- Gregory LeongDirector
- Peter M. O. WongExecutive Officer
- Michael O'Neill, Ph.D.Executive Officer
- Offering amount
- $43.1M
- Amount sold
- $25.5M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.